- Article
A Cell-Based Potency Assay for Determining the Relative Potency of Botulinum Neurotoxin A Preparations Using Manual and Semi-Automated Procedures
- F. Mark Dunning,
- Sara Hendrickson,
- Serena Wolfe,
- Dan Harding,
- Theresa Geurs,
- Timothy M. Piazza,
- Thomas A. Little and
- Ward C. Tucker
Cell-based potency assays (CBPAs) are required for the potency testing and commercial release of botulinum neurotoxin (BoNT)-based drug products. These CBPAs must account for the toxin’s biological activities while meeting regulatory guidelines...